European Journal of Clinical Pharmacology

ISSN: 0031-6970

Journal Guideline

European Journal of Clinical Pharmacology Q2 Unclaimed

Springer Verlag Germany

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

The European Journal of Clinical Pharmacology publishes original papers, reviews, and letters to the editors on all aspects of clinical pharmacology and drug therapy in humans. Coverage includes therapeutic trials; pharmacokinetics; drug metabolism; adverse drug reactions; drug interactions; all aspects of drug development; prescribing policies; pharmacoepidemiology; and matters relating to the safe use of drugs. Data from animal experiments are published only in the context of parallel experiments in man reported in the same paper. The journal also publishes review articles on special problems related to these areas, and encourages debate on controversial issues.Details Concerning the Submission and Publication Procedures:- No Page Charges- No Fees for Online Color Images- Optional Color Images in Print – EUR 950/USD 1150. VAT or local taxes will be added where applicable.- Optional Open Access Publication Fee (APC) - EUR 2990/USD 3760/GBP 2490. VAT or local taxes will be added where applicable. Covers all aspects of clinical pharmacology and drug therapy in humansReports on therapeutic trials; pharmacokinetics; drug metabolism; prescribing policies, and morePublishes review articles on special problems, and encourages debate on controversial issues98% of authors who answered a survey reported that they would definitely publish or probably publish in the journal againOfficial Journal of the European Association of Clinical Pharmacology & Therapeutics (EACPT) It has an SJR impact factor of 0,727.

European Journal of Clinical Pharmacology focuses its scope in these topics and keywords: drug, populationbased, review, bioavailability, schizophrenia, combination, controlled, reporting, syndrome, major, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q2) Pharmacology (Q2) Pharmacology (medical) (Q2) Pharmacology (medical) (Q2)

Price

3190 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

0,727

SJR Impact factor

123

H Index

163

Total Docs (Last Year)

626

Total Docs (3 years)

6493

Total Refs

1431

Total Cites (3 years)

530

Citable Docs (3 years)

2.25

Cites/Doc (2 years)

39.83

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Clinical Rheumatology Q2
Pharmacological Reports Q2
Journal of Human Nutrition and Dietetics Q2
Diseases of the Colon and Rectum Q2
Oncology Reports Q2

Compare this journals

Aims and Scope

Best articles by citations

Rifampicin reduces plasma concentrations of celiprolol

Pharmacokinetic modelling of cefotaxime and desacetylcefotaxime - a population study in 25 elderly patients

The use of a cyclosporin?ketoconazole combination: making renal transplantation affordable in developing countries

Methadone and edema: a case-report and literature review

Circulating levels of cyclosporin A in inflammatory bowel disease: relationships with lymphocyte inhibition and the age of patients

Use of psychotropics is high among very old people

A dose-response study of phenylephrine in critically ill, septic surgical patients

The validity of a questionnaire on medicines used in health care practice: comparison of a questionnaire and computerized medical record survey

Utilisation of antibiotics in young children: opposite relationships to adult educational levels in Danish and Swedish counties

Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid

The effect of long-term microcrystalline chitosan therapy on plasma lipids and glucose concentrations in subjects with increased plasma total cholesterol: a randomised placebo-controlled double-blind crossover trial in healthy men and women

Effect of the novel anxiolytic drug deramciclane on cytochrome P 450 2D6 activity as measured by desipramine pharmacokinetics

SHOW MORE ARTICLES

Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man

Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone

Influence of menthol on caffeine disposition and pharmacodynamics in healthy female volunteers

Concentration of ethambutol in cerebrospinal fluid in man as a function of the non-protein-bound drug fraction in serum

Validity of performance indicators for assessing prescribing quality: the case of asthma

The effects of omeprazole-induced hypochlorhydria on absorption of theophylline from a sustained-release formulation

Effects of SCH27899 (Ziracin), an oligosaccharide everninomicin antibiotic, on urate kinetics in humans

Impact of CYP2D6*10 on mexiletine pharmacokinetics in healthy adult volunteers

Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers

Concomitant occasional use of salbutamol influences bronchoprotective responsiveness afforded by formoterol in patients with the glycine-16 genotype

Biliary excretion and pharmacokinetics of ceftriaxone after cholecystectomy

Patterns of antihypertensive drug utilization in primary care